Irmgard Tegeder
Institut für Klinische Pharmakologie
Klinikum der Goethe-Universität Frankfurt
Theodor Stern Kai 7
Haus 74; 60590 Frankfurt am Main
Germany
Name/email consistency: high
- SNO-ing at the Nociceptive Synapse? Tegeder, I., Scheving, R., Wittig, I., Geisslinger, G. Pharmacol. Rev. (2011)
- Current evidence for a modulation of low back pain by human genetic variants. Tegeder, I., Lötsch, J. J. Cell. Mol. Med. (2009)
- Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?. Tegeder, I., Geisslinger, G. Naunyn Schmiedebergs Arch. Pharmacol. (2006)
- Peripheral opioid analgesia in experimental human pain models. Tegeder, I., Meier, S., Burian, M., Schmidt, H., Geisslinger, G., Lötsch, J. Brain (2003)
- G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Tegeder, I., Grösch, S., Schmidtko, A., Häussler, A., Schmidt, H., Niederberger, E., Scholich, K., Geisslinger, G. Cancer Res. (2003)
- Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer. Tegeder, I., Bräutigam, L., Seegel, M., Al-Dam, A., Turowski, B., Geisslinger, G., Kovács, A.F. Clin. Pharmacol. Ther. (2003)
- Tissue distribution of imipenem in critically ill patients. Tegeder, I., Schmidtko, A., Bräutigam, L., Kirschbaum, A., Geisslinger, G., Lötsch, J. Clin. Pharmacol. Ther. (2002)
- Release of algesic substances in human experimental muscle pain. Tegeder, L., Zimmermann, J., Meller, S.T., Geisslinger, G. Inflamm. Res. (2002)